The 900-page bill eliminates a 2006 program called Grad PLUS, which allowed students to borrow money up to the full cost of attendance.

Battered by multiple years of high health care costs, employers are planning to shift more of the expense to workers in 2026.

A groundbreaking drug, blinatumomab, is transforming leukemia treatment, offering new hope for patients like 4-year-old Madi Seivert.